Today news
The same in other media
Celltrion’s Covid-19 antibody therapy reduces viral load in animal tests
Reading now: 111
South Korea-based Celltrion Group has reported positive results from the preclinical tests of its Covid-19 antibody treatment, which led to a 100-fold decrease in the viral load of SARS-CoV-2.
The therapy demonstrated improvement in lung lesions to a normal activity level in animal models. The pre-clinical study was carried out in an animal model in alliance with Chungbuk National University College of Medicine.
The study was designed to evaluate the efficacy of high and low dosage levels of antibody therapy. According to the company, the treatment resulted in improved recovery in terms of clinical symptom scores such as cough and body aches, after the first day of therapy, when compared to placebo.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|